NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/18/2025
Back to search
Official data from USPTO
PREDICTSCRIPT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PREDICTSCRIPT
ST13
US500000097091070Class
42
Filing
97091070
Registration
7697879
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
02/18/2025
Trademark type
Word
Nice classes
42
Filing date
10/25/2021
Registration date
02/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-02-00
First use in commerce
2023-02-00
Drawing code
4
Owner type
03
Owner location
Plymouth, MI
Examiner
MAHONEY, KATHERINE
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Phenomics Health Inc.
Representatives
ROGER H. BORA THOMPSON HINE LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological services in the field of pharmaceuticals featuring scientific testinganalysis and evaluation of blood samples for the purpose of drug development by othersdata-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testinganalysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare servicesspecifically for improving the monitoring and diagnostics of quantitative patient drug exposurethe monitoring and diagnostics of patient drug compliancedata-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activitiesdrug dosage recommendationsinitial drug prescribingdrug switchingall for research purposes and not for medical purposes; genetic testing for scientific research purposesspecifically pharmacogenomic testinganalysisevaluation of buccalsaliva and other biological samples for the purposes of analyzing how the genetic makeup of an individual affects their response to drugsimproving drug selection and dosage recommendationsselecting initial and subsequent medicationsidentifying drug-drug interactionsavoiding adverse drug reactionsdeveloping clinical treatment decision support recommendationssupporting other medical diagnostic products and prescription drugs; genetic testing for scientific research purposesanalysis of multiple genes and genetic variants and their effect on drug response across multiple therapeutic areasincluding but not limited to psychiatrypaincardiologyoncology; scientific and technological services in the field of pharmaceuticals in the nature of scientific testinganalysis and evaluation of biological samples for research purposesspecifically research in the field of clinical trialsresearch in the field of new drug development and drug repurposing
Publications
History of USPTO decisions and trademark events.
49 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/27/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/27/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2025
ALIE
ASSIGNED TO LIE
01/24/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
01/13/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
01/13/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/15/2024
GNRT
NON-FINAL ACTION E-MAILED
10/15/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/15/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/15/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/15/2024
IUAF
USE AMENDMENT FILED
05/13/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/13/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/11/2024
EX1G
SOU EXTENSION 1 GRANTED
05/10/2024
EXT1
SOU EXTENSION 1 FILED
05/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/10/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/14/2023
EXPT
EXPARTE APPEAL TERMINATED
10/20/2023
EXPT
EXPARTE APPEAL TERMINATED
10/19/2023
EXDM
EXPARTE APPEAL DISMISSED AS MOOT
10/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/19/2023
PUBO
PUBLISHED FOR OPPOSITION
09/19/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/30/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/15/2023
EXPI
EX PARTE APPEAL-INSTITUTED
08/08/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
08/08/2023
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
08/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/03/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/27/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/27/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/10/2023
GNFR
FINAL REFUSAL E-MAILED
02/10/2023
CNFR
FINAL REFUSAL WRITTEN
02/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2022
GNRT
NON-FINAL ACTION E-MAILED
07/05/2022
CNRT
NON-FINAL ACTION WRITTEN
07/05/2022
DOCK
ASSIGNED TO EXAMINER
06/15/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2021
NWAP
NEW APPLICATION ENTERED
10/28/2021
Continuous trademark protection
Get notified about every new filing that threatens PREDICTSCRIPT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.